EP Patent

EP2384745A3 — Modified release pharmaceutical compositions of dexlansoprazole

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2012-01-18 · 14y expired

What this patent protects

The present invention is related to the modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and furthermore directed to processes for the manufacture of the tablet comp…

USPTO Abstract

The present invention is related to the modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and furthermore directed to processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2384745A3
Jurisdiction
EP
Classification
—
Expires
2012-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.